Skip to main content
Erschienen in: Acta Diabetologica 5/2017

01.10.2016 | Case Report

Treatment of diabetic gastroparesis with botulinum toxin injection guided by endoscopic ultrasound in a patient with type 1 diabetes: the first report

verfasst von: Heming Guo, Chen Fang, Yun Huang, Honghong Zhang, Xiaohong Chen, Duanming Hu, Ji Hu

Erschienen in: Acta Diabetologica | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

Diabetic gastroparesis is a well-recognized diabetic automatic neuropathy characterized by the delay of gastric emptying without gastric outlet obstruction. Upper gastrointestinal symptoms have been reported by up to 19 % of diabetic patients, and 48–65 % of these patients have been shown to have diabetic gastroparesis [1]. The cardinal symptoms include postprandial fullness, nausea, vomiting, and bloating. These symptoms caused by diabetic gastroparesis may result in malnutrition, malabsorbtion, impaired glucose control, and a poor quality of life. Patients with refractory diabetic gastroparesis who experience severe symptoms are not able to maintain sufficient nutritional intake and easily cause ketosis. Previous study revealed that diabetic gastroparesis was associated with higher mortality, morbidity, increased hospitalizations, emergency department, and doctor visits [2]. Primary treatment for diabetic gastroparesis includes correction of exacerbating factors, nutritional support, pharmacologic therapy, and surgical therapy. However, these options for patients have limitations such as high recurrence rate and various side effects. Botulinum toxin A injection is an alternative option for the treatment of diabetic gastroparesis by reducing intrapyloric muscular tone. Botulinum toxin A injection into the pyloric muscle was usually guided by endoscopies in previous studies. The limitations of endoscopic botulinum toxin A injection include uncertain depth of injection and the potential risk of perforation. Here, we present a case of intrapyloric botulinum toxin A injection guided by endoscopic ultrasound (EUS) in a patient with diabetic gastroparesis. …
Literatur
1.
Zurück zum Zitat Hasler WL (2011) Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol 8(8):438–453CrossRefPubMed Hasler WL (2011) Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol 8(8):438–453CrossRefPubMed
2.
Zurück zum Zitat Koch KL, Calles-Escandón J (2015) Diabetic Gastroparesis. Gastroenterol Clin North Am 44(1):39–57CrossRefPubMed Koch KL, Calles-Escandón J (2015) Diabetic Gastroparesis. Gastroenterol Clin North Am 44(1):39–57CrossRefPubMed
3.
Zurück zum Zitat Moraveji S, Bashashati M, Elhanafi S, Sunny J, Sarosiek I, Davis B et al (2016) Depleted interstitial cells of Cajal and fibrosis in the pylorus: novel features of gastroparesis. Neurogastroenterol Motil 28(7):1048–1054CrossRefPubMed Moraveji S, Bashashati M, Elhanafi S, Sunny J, Sarosiek I, Davis B et al (2016) Depleted interstitial cells of Cajal and fibrosis in the pylorus: novel features of gastroparesis. Neurogastroenterol Motil 28(7):1048–1054CrossRefPubMed
4.
Zurück zum Zitat D’Addio F, La Rosa S, Maestroni A, Jung P, Orsenigo E, Ben Nasr M et al (2015) Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy. Cell Stem Cell 17(4):486–498CrossRefPubMedPubMedCentral D’Addio F, La Rosa S, Maestroni A, Jung P, Orsenigo E, Ben Nasr M et al (2015) Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy. Cell Stem Cell 17(4):486–498CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ (2004) The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 27(10):2341–2347CrossRefPubMed Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ (2004) The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 27(10):2341–2347CrossRefPubMed
Metadaten
Titel
Treatment of diabetic gastroparesis with botulinum toxin injection guided by endoscopic ultrasound in a patient with type 1 diabetes: the first report
verfasst von
Heming Guo
Chen Fang
Yun Huang
Honghong Zhang
Xiaohong Chen
Duanming Hu
Ji Hu
Publikationsdatum
01.10.2016
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 5/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0920-7

Weitere Artikel der Ausgabe 5/2017

Acta Diabetologica 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.